OPKO Health to Participate in Two Upcoming Investment Conferences
OPKO Health, Inc. (NASDAQ: OPK) has announced participation in two significant virtual investor conferences in September 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OPKO Health, Inc. (NASDAQ: OPK) has announced participation in two significant virtual investor conferences in September 2021. The 14th Annual Barrington Research Fall Conference will take place on September 9, 2021, featuring one-on-one and small-group meetings with management. Subsequently, OPKO will attend the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021, where management will engage in a fireside chat and additional investor meetings. A recording of the fireside chat will be available on OPKO's website starting September 13.
Details
News Market Reaction – OPK
The recorded move for OPK in the trading session of this news was -0.52%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, Aug. 30, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in two upcoming virtual investor conferences.
- 14th Annual Barrington Research Fall Conference, September 9, 2021. Management will be available for one-on-one and small-group virtual meetings with investors during the event.
- H.C. Wainwright 23rd Annual Global Investment Conference, September 13-15, 2021. Management will participate in a fireside chat and will be available for one-on-one virtual meetings with investors. The recorded fireside chat will be available on demand beginning Monday, September 13th on the Investors section of OPKO Health’s website.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.